HNSA — Hansa Biopharma AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual balance sheet for Hansa Biopharma AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	1,378	889	1,496	732	405
Net Total Accounts Receivable
Net Total Receivables	10.1	32.3	65	91.8	160
Total Inventory
Prepaid Expenses
Total Current Assets	1,393	942	1,605	855	585
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	9.7	41.7	35.8	27.1	17.9
Net Intangible Assets
Total Assets	1,434	1,013	1,687	1,018	801
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	114	171	265	321	256
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	192	255	1,084	1,186	1,390
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	1,242	758	603	-168	-590
Total Liabilities & Shareholders' Equity	1,434	1,013	1,687	1,018	801
Total Common Shares Outstanding